InTest’s Q1 2026: Diversification Delivers a Breath of Fresh Margin for INTT

Key Takeaways at a Glance

• Ticker: INTT (InTest Corporation); Exchange: NYSE American.
• Revenue for the first quarter of 2026: $33.9 million, up 27.2% year over year.
• GAAP EPS: $0.06; Adjusted EPS (Non‑GAAP): $0.16.
• Gross margin: 45.5%, supported by higher volume and favorable product mix.
• Orders: $31.8 million, up 25.4% YoY but down sequentially from two quarters of record orders.
• Net earnings: $0.8 million; Adjusted EBITDA (Non‑GAAP): $3.2 million.
• Revenue guidance raised for 2026 to a range of $130 million to $135 million.
• End-market mix: 69% of revenue from non‑semiconductor end markets, with Defense/Aerospace, Life Sciences, and Auto/EV driving growth; Semiconductor business also improving on backlog-driven shipments.

What the numbers say, with a reader’s-eye tilt

InTest’s quarter reads like a company that found a few lanes and decided not to drive back into the ditch. Revenue acceleration is broad-based and helped by a diversified mix of customers beyond semiconductors. The 69% share from non‑semiconductor end markets hints at resilience where the company can leverage its test and process expertise across Defense/Aerospace, Life Sciences, and Auto/EV. Meanwhile, the semiconductor segment is finally showing improvement as backlog shipments move through the pipeline.

The EPS figures—$0.06 on the GAAP line and $0.16 on the adjusted line—stack up with a narrative of modest profitability rather than a jaw-dropping earnings surprise. Management framed the quarter as slightly ahead of guidance, which is a respectable way to say the street’s expectations probably didn’t collapse, but neither did they glow. In other words, this is the kind of result that earns a quiet nod rather than a standing ovation.

Strategic Signals and the Operating Playbook

The margin story matters as much as the top line. Gross margin at 45.5% reflects both volume and mix benefits, suggesting the company is successfully pricing and delivering higher‑value output within its portfolio. The adjusted EBITDA figure of $3.2 million reinforces that the business is generating cash flow even as it invests in growth avenues.

Management highlights a deliberate focus on operational discipline, including cost management and supply‑chain efficiency. There’s also a clear emphasis on capital allocation via organic innovation, global expansion, and targeted M&A. The “top priority” of deepening connections across the platform hints at a strategy built on cross‑sell and integration, not just adding more bolt‑on assets. The narrative here is not a one‑quarter sprint—it’s a multi‑quarter plan to lift gross margins and EBITDA over time.

The revenue forecast for 2026 has been raised to a range of $130 million to $135 million. That move matters: guidance upgrades are the natural currency of a company trying to convert backlog and cross‑market demand into a steady annual cadence. And while orders did slip from the prior quarter’s peak, the continued growth in non‑semiconductor end markets suggests the demand base remains robust, not merely a one‑time spike.

What This Might Portend for INTT and Its Peers

• Diversification as a hedge: A heavy tilt toward non‑semiconductor end markets can dampen cyclicality. Investors may view INTT as a model for how suppliers can shield profits when a single market softens.
• Backlog as a near‑term engine: The backlog‑driven shipments in the semiconductor segment show management’s ability to convert pipeline into revenue, albeit with near‑term order volatility. The balance between backlog conversion and new orders will be a focal point for the rest of the year.
• Margins matter more than headlines: The 45.5% gross margin, paired with disciplined cost control, may be the more dramatic story than the headline revenue growth. Sustaining margin expansion will be key to any longer‑term multiple expansion.
• M&A and capital discipline: Management’s emphasis on strategic acquisitions and rigorous capital deployment could redefine the company’s scale and product moat over time, especially if cross‑business product development accelerates.
• Sector read‑through: Other test and process technology suppliers with diversified end markets may benefit from InTest’s playbook if customers accelerate investment across defense, life sciences, and automotive tech, particularly EVs, where testing cycles can be sticky and recurring.

Risks and Considerations

The road ahead is not without potholes. Macro demand in certain end markets can wobble, and even diversified revenue streams are not immune to supply‑chain hiccups or shifts in customer buying, especially if capital cycles in defense, biotech, or auto/EV slow. The reliance on backlog for near‑term orders means execution discipline and supplier performance will be under the microscope.

What to Watch Next

Investors will likely zero in on three things: (1) the sustainability of the revenue forecast for 2026, (2) whether the non‑semiconductor mix remains robust as the year unfolds, and (3) how the company handles margin progression as it scales in a mixed market environment. The presence of an EPS figure and an adjusted EPS line gives analysts a yardstick, but the real cliffhanger is how the EPS consensus for INTT evolves as further quarters roll in and backlog conversion accelerates.

From the CEO’s Desk

“InTest delivered a good start to 2026, with first quarter results slightly ahead of guidance,” said Rich Rogoff, President and CEO. “With 69% of revenue generated from non‑semiconductor end markets, we saw strong year‑over‑year growth across Defense/Aerospace, Life Sciences, and Auto/EV. Our Semi business improved, benefitting from shipments from our backlog rather than first quarter orders.” The leadership emphasis on cross‑business collaboration and margin expansion suggests a deliberate path toward stronger free cash flow and shareholder returns over time.